Skip Navigation


Hum. Reprod. Advance Access originally published online on April 14, 2005
Human Reproduction 2005 20(8):2237-2241; doi:10.1093/humrep/dei029
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow All Versions of this Article:
20/8/2237    most recent
dei029v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Heindryckx, B.
Right arrow Articles by Dhont, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Heindryckx, B.
Right arrow Articles by Dhont, M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions{at}oupjournals.org

Treatment option for sperm- or oocyte-related fertilization failure: assisted oocyte activation following diagnostic heterologous ICSI

B. Heindryckx1, J. Van der Elst, P. De Sutter and M. Dhont

Infertility Centre, Ghent University Hospital, De Pintelaan 185, 9000 Ghent, Belgium

1 To whom correspondence should be addressed. Email: bjorn.heindryckx{at}ugent.be

BACKGROUND: Failed fertilization occurs in 2–3% of ICSI cycles and is mainly due to lack of oocyte activation. Heterologous ICSI of patient's sperm in mouse oocytes allows discrimination between sperm- and oocyte-related aetiologies of activation failure. Assisted oocyte activation (AOA) by Ca-ionophore treatment can initiate fertilization in subsequent therapeutic ICSI. We report on diagnosis and clinical treatment in 17 patients with previously failed fertilization. METHODS: Sperm from patients were injected into mature mouse oocytes. Activation capacity was assessed by 2-cell formation (mouse oocyte activation test, MOAT). When no activation occurred, it was assumed that the spermatozoon was deficient; otherwise an oocyte-related factor was suspected. In a subsequent ICSI cycle, AOA was done by ICSI with CaCl2 followed by a Ca2+ ionophore exposure. Fertilization was checked 16–20 h later. Embryo transfer was on day 2 or 3. RESULTS: MOAT showed sperm-related activation deficiency in six globozoospermic patients and two patients with extreme oligoasthenoteratozoospermia. One patient with small sperm acrosomes had a normal activation percentage. In eight other patients, the MOAT revealed a relatively normal activation capacity of the sperm, indicating an oocyte-related defect. After AOA, fertilization rates were 77 and 71% in the sperm- and oocyte-related groups respectively. Five pregnancies were achieved in the globozoospermia group and three in cases of oocyte-related activation failure. CONCLUSIONS: Assisted oocyte activation enables normal fertilization and pregnancy in sperm- and oocyte-related fertilization failure.

Key words: calcium ionophore/fertilization failure/heterologous ICSI/oocyte activation


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Hum ReprodHome page
E. Heytens, J. Parrington, K. Coward, C. Young, S. Lambrecht, S.-Y. Yoon, R.A. Fissore, R. Hamer, C.M. Deane, M. Ruas, et al.
Reduced amounts and abnormal forms of phospholipase C zeta (PLC{zeta}) in spermatozoa from infertile men
Hum. Reprod., October 1, 2009; 24(10): 2417 - 2428.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
P. Grasa, K. Coward, C. Young, and J. Parrington
The pattern of localization of the putative oocyte activation factor, phospholipase C{zeta}, in uncapacitated, capacitated, and ionophore-treated human spermatozoa
Hum. Reprod., November 1, 2008; 23(11): 2513 - 2522.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
J. E. Swain and T. B. Pool
ART failure: oocyte contributions to unsuccessful fertilization
Hum. Reprod. Update, September 1, 2008; 14(5): 431 - 446.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
H. Fulka, I. Barnetova, T. Mosko, and J. Fulka
Epigenetic analysis of human spermatozoa after their injection into ovulated mouse oocytes
Hum. Reprod., March 1, 2008; 23(3): 627 - 634.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
Y. Yu, C.M. Saunders, F.A. Lai, and K. Swann
Preimplantation development of mouse oocytes activated by different levels of human phospholipase C zeta
Hum. Reprod., February 1, 2008; 23(2): 365 - 373.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
The ESHRE Capri Workshop Group
Intracytoplasmic sperm injection (ICSI) in 2006: Evidence and Evolution
Hum. Reprod. Update, November 1, 2007; 13(6): 515 - 526.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
B. Heindryckx, P. De Sutter, J. Gerris, M. Dhont, and J. Van der Elst
Embryo development after successful somatic cell nuclear transfer to in vitro matured human germinal vesicle oocytes
Hum. Reprod., July 1, 2007; 22(7): 1982 - 1990.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
A.H.D.M. Dam, I. Feenstra, J.R. Westphal, L. Ramos, R.J.T. van Golde, and J.A.M. Kremer
Globozoospermia revisited
Hum. Reprod. Update, January 1, 2007; 13(1): 63 - 75.
[Abstract] [Full Text] [PDF]


Home page
J AndrolHome page
A. Ahmady and E. Michael
Successful Pregnancy and Delivery Following Intracytoplasmic Injection of Frozen-Thawed Nonviable Testicular Sperm and Oocyte Activation With Calcium Ionophore
J Androl, January 1, 2007; 28(1): 13 - 14.
[Full Text] [PDF]


Home page
Biol. Reprod.Home page
A. Ajduk, Y. Yamauchi, and M. A Ward
Sperm Chromatin Remodeling after Intracytoplasmic Sperm Injection Differs from That of In Vitro Fertilization
Biol Reprod, September 1, 2006; 75(3): 442 - 451.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.